Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution.

Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP.

Mol Imaging Biol. 2018 Nov 7. doi: 10.1007/s11307-018-1293-9. [Epub ahead of print]

PMID:
30406512
2.

Dynamic whole-body PET imaging: principles, potentials and applications.

Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, Cho S, Zaidi H, Casey ME, Wahl RL.

Eur J Nucl Med Mol Imaging. 2018 Sep 29. doi: 10.1007/s00259-018-4153-6. [Epub ahead of print] Review.

PMID:
30269154
3.

Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle.

Lodge MA, Leal JP, Rahmim A, Sunderland JJ, Frey EC.

J Nucl Med. 2018 Nov;59(11):1768-1775. doi: 10.2967/jnumed.118.209593. Epub 2018 Jun 14.

PMID:
29903932
4.

Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation.

Foss CA, Plyku D, Ordonez AA, Sanchez-Bautista J, Rosenthal HB, Minn I, Lodge MA, Pomper MG, Sgouros G, Jain SK.

J Nucl Med. 2018 Nov;59(11):1751-1756. doi: 10.2967/jnumed.117.207431. Epub 2018 Apr 26.

PMID:
29700124
5.

Feasibility of state of the art PET/CT systems performance harmonisation.

Kaalep A, Sera T, Rijnsdorp S, Yaqub M, Talsma A, Lodge MA, Boellaard R.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1344-1361. doi: 10.1007/s00259-018-3977-4. Epub 2018 Mar 2.

6.

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

Plyku D, Mena E, Rowe SP, Lodge MA, Szabo Z, Cho SY, Pomper MG, Sgouros G, Hobbs RF.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):989-998. doi: 10.1007/s00259-018-3939-x. Epub 2018 Feb 19.

7.

Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.

Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Abraham MR.

J Nucl Cardiol. 2018 Feb 8. doi: 10.1007/s12350-018-1228-5. [Epub ahead of print]

PMID:
29423907
8.

Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.

Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Roselle Abraham M.

J Nucl Cardiol. 2018 Jan 22. doi: 10.1007/s12350-017-1155-x. [Epub ahead of print] Erratum in: J Nucl Cardiol. 2018 Feb 8;:.

PMID:
29359273
9.

Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network.

Byrd D, Christopfel R, Arabasz G, Catana C, Karp J, Lodge MA, Laymon C, Moros EG, Budzevich M, Nehmeh S, Scheuermann J, Sunderland J, Zhang J, Kinahan P.

J Med Imaging (Bellingham). 2018 Jan;5(1):011016. doi: 10.1117/1.JMI.5.1.011016. Epub 2018 Jan 4.

PMID:
29322068
10.

Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms.

Mhlanga JC, Chirindel A, Lodge MA, Wahl RL, Subramaniam RM.

Nucl Med Commun. 2018 Feb;39(2):154-160. doi: 10.1097/MNM.0000000000000786.

PMID:
29227348
11.

Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom.

Mansor S, Pfaehler E, Heijtel D, Lodge MA, Boellaard R, Yaqub M.

Med Phys. 2017 Dec;44(12):6413-6424. doi: 10.1002/mp.12623. Epub 2017 Nov 19.

12.

ACR-SPR-STR Practice Parameter for the Performance of Cardiac Positron Emission Tomography - Computed Tomography (PET/CT) Imaging.

Subramaniam RM, Janowitz WR, Johnson GB, Lodge MA, Parisi MT, Ferguson MR, Hellinger JC, Gladish GW, Gupta NK.

Clin Nucl Med. 2017 Dec;42(12):918-927. doi: 10.1097/RLU.0000000000001827.

PMID:
28922191
13.

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Holdhoff M, Ye X, Supko JG, Nabors LB, Desai AS, Walbert T, Lesser GJ, Read WL, Lieberman FS, Lodge MA, Leal J, Fisher JD, Desideri S, Grossman SA, Wahl RL, Schiff D.

Neuro Oncol. 2017 Jun 1;19(6):845-852. doi: 10.1093/neuonc/nox020.

14.

The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study.

Jackson S, George RT, Lodge MA, Piotrowski A, Wahl RL, Gujar SK, Grossman SA.

J Neurooncol. 2017 May;132(3):513-519. doi: 10.1007/s11060-017-2404-1. Epub 2017 Mar 17.

PMID:
28315063
15.

Enhancing ejection fraction measurement through 4D respiratory motion compensation in cardiac PET imaging.

Tang J, Wang X, Gao X, Segars WP, Lodge MA, Rahmim A.

Phys Med Biol. 2017 Jun 7;62(11):4496-4513. doi: 10.1088/1361-6560/aa6417. Epub 2017 Mar 2.

PMID:
28252451
16.

Repeatability of SUV in Oncologic 18F-FDG PET.

Lodge MA.

J Nucl Med. 2017 Apr;58(4):523-532. doi: 10.2967/jnumed.116.186353. Epub 2017 Feb 23. Review.

17.

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial.

Pili R, Liu G, Chintala S, Verheul H, Rehman S, Attwood K, Lodge MA, Wahl R, Martin JI, Miles KM, Paesante S, Adelaiye R, Godoy A, King S, Zwiebel J, Carducci MA.

Br J Cancer. 2017 Mar 28;116(7):874-883. doi: 10.1038/bjc.2017.33. Epub 2017 Feb 21.

18.

Simplifying volumes-of-interest (VOIs) definition in quantitative SPECT: Beyond manual definition of 3D whole-organ VOIs.

Vicente EM, Lodge MA, Rowe SP, Wahl RL, Frey EC.

Med Phys. 2017 May;44(5):1707-1717. doi: 10.1002/mp.12164. Epub 2017 Mar 28.

19.

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC.

Crandall JP, Tahari AK, Juergens RA, Brahmer JR, Rudin CM, Esposito G, Subramaniam DS, Knopp MV, Hall NC, Gajwani P, Leal JP, Lodge MA, O JH, Gabrielson EW, Shankar LK, Wahl RL.

EJNMMI Res. 2017 Dec;7(1):8. doi: 10.1186/s13550-017-0258-3. Epub 2017 Jan 19.

20.

Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.

Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, Pienta KJ, Lodge MA, Pomper MG.

J Nucl Med. 2017 Jun;58(6):942-946. doi: 10.2967/jnumed.116.179739. Epub 2016 Dec 8.

Supplemental Content

Loading ...
Support Center